tirzepatide latest news New weight loss drug could break sales records Tirzepatide vs. semaglutide: Study compares

5 Improved Blood Sugar & Metabolic Health GLP-1 therapy improves insulin sensitivity, stabilizes blood sugar levels, and lowers HbA1c, delivering benefits that go far beyond weight loss, including reduced cardiovascular risk and long-term metabolic health improvement

Consider staying at 7.5 mg if: You are losing 1 to 2 pounds per week consistently Appetite suppression is adequate to maintain a caloric deficit Side effects are minimal and manageable You are comfortable with the cost at this dose level Consider continuing to 10 mg if: Weight loss has plateaued for more than 3 weeks at 7.5 mg Appetite suppression has diminished significantly Your target weight is still far from current weight Side effects at 7.5 mg are mild and tolerable Many researchers use the troubleshooting guide to determine whether a dose increase is the right move or whether other factors like dietary compliance or sleep quality are affecting results

Both formats demonstrate clinical efficacy in randomized trials for weight reduction and glucose management

In a Korean observational study, nearly half of those with gestational diabetes developed T2DM within 10 years of delivery [1038]

While treatments have come a long way, theres still room for improvement, especially regarding prevention